CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patients
CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patients
批准号:
10158737
负责人:
MARLA J KELLER
金额:
$100.34万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-09 至 2021-02-28
关键词:
2019-nCoVAcuteAcute respiratory failureAddressAdministrative SupplementAdult Respiratory Distress SyndromeArrhythmiaArtificial IntelligenceAwardAwarenessCOVID-19COVID-19 pandemicCessation of lifeClinicalClinical DataClinical Decision Support SystemsClinical ResearchCollaborationsCommunitiesCompetenceComplexCoronavirusDataData ScienceData ScientistDetectionDeteriorationDevelopmentDiagnosisEngineeringExpert SystemsFatal OutcomeFunctional disorderFundingFutureGenerationsGoalsHealthHealth systemHealthcareHeart InjuriesHospitalsHypoxemiaInfectionInformaticsInjury to KidneyInpatientsInstitutesInterventionLeadLifeLinkLiteratureLung ComplianceMechanical ventilationMedical centerMethodsModelingMorbidity - disease rateNew York CityOrganParentsPatientsPneumoniaPopulationPreventiveProcessPublic HealthPublishingResearchResearch PersonnelResearch SupportResourcesRespiratory FailureRisk AssessmentSeasonsSeveritiesSoftware EngineeringSourceStandardizationSystemThromboembolismTimeTrainingTranslatingTranslational ResearchUnited States National Institutes of HealthUpper Respiratory Infectionsbasecare deliverycare providersclinical decision-makingcohortcomplex data coronavirus diseasedata modelingdeep learningdesignevidence baseexperiencefluhealth datainfection rateinnovationmachine learning algorithmmortalitymultidisciplinarynovelpandemic diseasepreemptive interventionpreventprognosticprogramsresponsesoftware systemstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) proposes an Administrative
Supplement pursuant to NOT-TR-20-011, CTSA Program Applications to Address 2019 Novel Coronavirus
(Covid-19). Specifically, this application addresses the urgent need for research on the coronavirus pandemic
with a project focusing on informatics and data science to preemptively identify patients with the life-
threatening complications of SARS-CoV-2, using CTSA-supported core resources. Characterized by severe
hypoxemia, tachypnea, and decreased lung compliance, the diagnosis of acute respiratory failure (ARF) is a
bad prognostic sign, and in a subset, leads to development of acute respiratory distress syndrome (ARDS).
The rates of Covid-19 infection and death in the Bronx have been higher than any other borough of NYC. As
the major regional health system, our experience with Covid-19 provides guideposts that may prevent future
victims of this pandemic. The bleak picture for ARDS in the 4,452 patients admitted showed that 78% of our
intubated Covid-19 patients developed ARDS, with 42% mortality. The overall goal of this proposal is to
leverage our novel informatics and analytics platforms enabled by the Einstein-Montefiore CTSA (NIH/NCATS
1ULTR002556), and extensive Artificial Intelligence and Deep Learning resources to implement a novel,
situational awareness and clinical decision support system for ARF and ARDS (SA-ARDS). We will re-train our
existing deep learning models with data collected from Covid-19 patients and contextualize its implementation
with data from the Covid-19 response during the pandemic in NYC. The SA-ARDS data platform will provide
longitudinally integrated clinical data for research and multi-institutional and national collaborations, with the
following specific aims: Aim 1: To integrate, re-train, and validate our novel, near real-time, Electronic Risk
Assessment System (ERAS 1.0) optimized for early recognition of ARF, ARDS, and inpatient mortality; Aim 2:
To develop an evidence based, real-time, and context appropriate Situational Awareness clinical decision
support system targeting ARF and ARDS response (SA-ARDS); and Aim 3: Through our partner CTSA
organizations, to standardize and disseminate ERAS 1.0 and the SA-ARDS to other health systems, including
the NYC consortium of CTSA hubs and the PCORI INSIGHT network. We will use the clinical data underlying
the SA-ARDS to support research in local, regional, and national collaborations. All the methods and tools
developed will be shared with the CTSA community via NCATS' National Center for Data to Health (CD2H).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Einstein-Montefiore Clinical and Translational Science Award Hub
-
批准号:10622099
-
项目类别:
-
资助金额:$436.8万
-
财政年份:2023
-
负责人:MARLA J KELLER
-
依托单位:
Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 hospitalized pa
-
批准号:10166008
-
项目类别:
-
资助金额:$432.52万
-
财政年份:2020
-
负责人:MARLA J KELLER
-
依托单位:
Clinical and Translational Science Award
-
批准号:10112978
-
项目类别:
-
资助金额:$427.42万
-
财政年份:2018
-
负责人:MARLA J KELLER
-
依托单位:
Clinical and Translational Science Award
-
批准号:9886296
-
项目类别:
-
资助金额:$427.42万
-
财政年份:2018
-
负责人:MARLA J KELLER
-
依托单位:
Clinical and Translational Science Award
-
批准号:10357784
-
项目类别:
-
资助金额:$427.42万
-
财政年份:2018
-
负责人:MARLA J KELLER
-
依托单位:
Modifies of PrEP Efficacy in US & African Women: Age, Hormones, Sex & Microbiota
-
批准号:8448509
-
项目类别:
-
资助金额:$89.57万
-
财政年份:2013
-
负责人:MARLA J KELLER
-
依托单位:
Safety of Non-Medicated Intravaginal Rings for Microbicide Delivery
-
批准号:8012508
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2010
-
负责人:MARLA J KELLER
-
依托单位:
Clinical Study to Measure Pharmacokinetics, Pharmacodynamics and Safety of a TDF
-
批准号:8210597
-
项目类别:
-
资助金额:$46.11万
-
财政年份:2009
-
负责人:MARLA J KELLER
-
依托单位:
EFFECTS OF HORMONES ON MUCOSAL IMMUNE MEDIATORS ACROSS THE MENSTRUAL CYCLE
-
批准号:7718170
-
项目类别:
-
资助金额:$17.93万
-
财政年份:2008
-
负责人:MARLA J KELLER
-
依托单位:
EFFECTS OF HORMONES ON MUCOSAL IMMUNE MEDIATORS ACROSS THE MENSTRUAL CYCLE
-
批准号:7605356
-
项目类别:
-
资助金额:$3.4万
-
财政年份:2007
-
负责人:MARLA J KELLER
-
依托单位:
THE EFFICACY OF SAMMA AND ITS LEADING DERIVATIVES AGAINST HIV-1
-
批准号:7605277
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2007
-
负责人:MARLA J KELLER
-
依托单位:
EFFECTS OF HIV ON BONE MASS IN THE ELDERLY
-
批准号:7380524
-
项目类别:
-
资助金额:$4.59万
-
财政年份:2006
-
负责人:MARLA J KELLER
-
依托单位:
EFFECT OF REPEATED APPLICATIONS OF PRO 2000/5 GEL (P) ON INFLAMMATORY MEDIATORS
-
批准号:7380538
-
项目类别:
-
资助金额:$2.69万
-
财政年份:2006
-
负责人:MARLA J KELLER
-
依托单位:
MULTITARGETED MICROBICIDE COMBINATIONS TO BLOCK HIV
-
批准号:7380518
-
项目类别:
-
资助金额:$5.38万
-
财政年份:2006
-
负责人:MARLA J KELLER
-
依托单位:
TO EVALUATE THE EFFICACY OF SAMMA AND ITS LEADING DERIVATIVES AGAINST HIV-1
-
批准号:7380526
-
项目类别:
-
资助金额:$4.9万
-
财政年份:2006
-
负责人:MARLA J KELLER
-
依托单位:
Microbicide Effects on Efficacy, Safety, Innate Immunity
-
批准号:7572920
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2005
-
负责人:MARLA J KELLER
-
依托单位:
Microbicide Effects on Efficacy, Safety, Innate Immunity
-
批准号:7531462
-
项目类别:
-
资助金额:$20.01万
-
财政年份:2005
-
负责人:MARLA J KELLER
-
依托单位:
Microbicide Effects on Efficacy, Safety, Innate Immunity
-
批准号:7221949
-
项目类别:
-
资助金额:$20.74万
-
财政年份:2005
-
负责人:MARLA J KELLER
-
依托单位:
EFFECT OF REPEATED APPLICATIONS OF PRO 2000/5 GEL (P) ON INFLAMMATORY MEDIATO
-
批准号:7202511
-
项目类别:
-
资助金额:$11.22万
-
财政年份:2005
-
负责人:MARLA J KELLER
-
依托单位:
MULTITARGETED MICROBICIDE COMBINATIONS TO BLOCK HIV
-
批准号:7202486
-
项目类别:
-
资助金额:$7.16万
-
财政年份:2005
-
负责人:MARLA J KELLER
-
依托单位:
海外基金